These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15831978)

  • 21. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel antiplatelet therapies following percutaneous coronary interventions.
    Ahrens I; Bode C
    Curr Opin Investig Drugs; 2009 Sep; 10(9):902-11. PubMed ID: 19705332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
    Beijk MA; Piek JJ
    Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
    Kandzari DE; Tcheng JE; Zidar JP
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):562-76. PubMed ID: 12124974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
    Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
    Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents].
    Stenestrand U
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2838-9. PubMed ID: 17128915
    [No Abstract]   [Full Text] [Related]  

  • 28. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-restenosis study on a new drug eluting stent].
    Zhao A; Zhang H; Huang N; Zhang B; Yang K; Li Z; Zhao H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):856-9, 878. PubMed ID: 18788296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting stents: a comprehensive appraisal.
    Butt M; Connolly D; Lip GY
    Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.
    Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R
    Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The paclitaxel-eluting stent in percutaneous coronary intervention: part I: background and clinical comparison to bare metal stents.
    Gruchalla KJ; Nawarskas JJ
    Cardiol Rev; 2006; 14(2):88-98. PubMed ID: 16493246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents.
    Otsuka Y; Chronos NA; Apkarian RP; Robinson KA
    J Invasive Cardiol; 2007 Feb; 19(2):71-6. PubMed ID: 17268041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Percutaneous coronary intervention].
    Csapó K
    Orv Hetil; 2005 Mar; 146(13):587-93. PubMed ID: 15856622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.